Mesalazine Therapy in Patients With Irritable Bowel Syndrome
Clinical trial NCT00626288 · COMPLETED
Trial details
- NCT number
- NCT00626288
- Sponsor
- SOFAR S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2012-03-01
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.